Advertisement
U.S. markets close in 3 hours 43 minutes
Advertisement

Ampio Pharmaceuticals, Inc. (AMPE)

NYSE American - Nasdaq Real Time Price. Currency in USD
Visitors trend2W10W9M
2.0300-0.0500 (-2.40%)
As of 11:54AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Inverted Hammer

Inverted Hammer

Performance Outlook
Previous Close2.0800
Open2.0800
Bid2.0300 x 800
Ask2.0600 x 1000
Day's Range2.0200 - 2.0981
52 Week Range2.0200 - 9.0000
Volume13,303
Avg. Volume32,819
Market Cap1.689M
Beta (5Y Monthly)1.83
PE Ratio (TTM)N/A
EPS (TTM)-11.7000
Earnings DateNov 14, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for AMPE

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Ampio Pharmaceuticals, Inc.
    Analyst Report: Pfizer Inc.Pfizer is a leading developer and manufacturer of pharmaceuticals and biotech drugs. Its products include oncology and immunology drugs, treatments for rare diseases, and vaccines.
    Rating
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more
  • GlobeNewswire

    Presenting on the Emerging Growth Conference 64 Day 2 on November 2 Register Now

    MIAMI, Nov. 01, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 64th Emerging Growth Conference on November 1st and 2nd, 2023. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the conference here. Submit Questions for any of the presenting

  • PR Newswire

    Ampio Pharmaceuticals to Present at the Emerging Growth Conference

    Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company), a pre-revenue stage biopharmaceutical company focused on development of a potential treatment for osteoarthritis as part of its OA-201 program, today announced that its CEO, Michael A. Martino will present in the Emerging Growth Conference on Thursday, November 2, 2023, at 1:10 pm ET.

  • PR Newswire

    Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201

    Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company), a pre-revenue stage biopharmaceutical company focused on development of a potential treatment for osteoarthritis as part of its OA-201 program, today announced that it has selected Ascendia Pharmaceuticals, Inc. ("Ascendia") to provide services to support the clinical development of OA-201, a novel therapeutic for the treatment of symptomatic osteoarthritis pain. OA-201 consists of a natural metabolite, formulated as an injectable